304 related articles for article (PubMed ID: 14139143)
21. [PROGRESS IN THE FIELD OF GYNECOLOGY WITH SPECIAL REFERENCE TO ENDOCRINOLOGY].
LAURITZEN C
Dtsch Med J; 1963 Oct; 14():644-53. PubMed ID: 14099770
[No Abstract] [Full Text] [Related]
22. ORAL CONTRACEPTIVES AND CORONARY THROMBOSIS.
LLOYD G
Br Med J; 1965 Feb; 1(5434):587-8. PubMed ID: 14243067
[No Abstract] [Full Text] [Related]
23. SOME MEDICAL ASPECTS OF ORAL CONTRACEPTIVES.
BRAIN ; PARKES AS; BISHOP PM
Lancet; 1964 Dec; 2(7373):1329-32. PubMed ID: 14224044
[No Abstract] [Full Text] [Related]
24. Gonadotropic activation of prevulatory synthesis and release of progestin in the rabbit.
HILLIARD J; ARCHIBALD D; SAWYER CH
Endocrinology; 1963 Jan; 72():59-66. PubMed ID: 13954592
[No Abstract] [Full Text] [Related]
25. RELATION OF ARTERIOLES IN THE ENDOMETRIUM TO HEADACHE FROM ORAL CONTRACEPTIVES.
GRAND EC
Lancet; 1965 May; 1(7396):1143-4. PubMed ID: 14287319
[No Abstract] [Full Text] [Related]
26. THE EFFECT OF GONADOTROPHINS OBSERVED AT LAPAROTOMY IN PATIENTS TREATED WITH 6-DEHYDRO-6-METHYL-17-ACETOXY-PROGESTERONE (DMAP)+ETHINYL-ESTRADIOL-3-METHYLETHER (EE3ME) FOR INHIBITION OF THE OVULATION.
STARUP J; OSTERGAARD E
Acta Obstet Gynecol Scand; 1965; 43():SUPPL 7:40-1. PubMed ID: 14286744
[No Abstract] [Full Text] [Related]
27. CENTRAL AND PERIPHERAL ACTION OF FERTILITY-INHIBITING PROGESTOGENS.
HECHT-LUCARI G
Int J Fertil; 1964; 9():205-16. PubMed ID: 14106259
[No Abstract] [Full Text] [Related]
28. [MEDICAL INDICATION FOR THE INHIBITION OF OVULATION].
PEETERS F; VANROY M; OEYEN R; SNAUWAERT R; VANTILBORG A
Internist (Berl); 1964 Jun; 5():246-51. PubMed ID: 14234762
[No Abstract] [Full Text] [Related]
29. [APROPOS OF THE OVULATION-INHIBITING DOSAGE OF ORAL GESTAGENS].
SZONTAGH FE; SAS M
Zentralbl Gynakol; 1964 Mar; 86():410-2. PubMed ID: 14198198
[No Abstract] [Full Text] [Related]
30. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
Doyen J; Schaaps JP; Lambotte R
Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
[TBL] [Abstract][Full Text] [Related]
31. THE INHIBITION OF OVULATION WITH ORAL PROGESTATIVE SUBSTANCES.
KAISER R
Int J Fertil; 1964; 9():87-93. PubMed ID: 14106272
[No Abstract] [Full Text] [Related]
32. EFFECT OF NORETHINDRONE ACETATE UPON GONADOTROPIN-INDUCED OVARIAN FUNCTION.
TAYMOR ML; RIZKALLAH T
J Clin Endocrinol Metab; 1965 Jun; 25():843-51. PubMed ID: 14296270
[No Abstract] [Full Text] [Related]
33. THE DIFFICULTIES AND DANGERS OF ORAL CONTRACEPTION.
MILLS WG
Proc R Soc Med; 1964 Mar; 57(3):207-10. PubMed ID: 14130874
[No Abstract] [Full Text] [Related]
34. COMPARISON OF THE ANTI-FERTILITY AND SEX HORMONAL ACTIVITIES OF SEX HORMONES AND THEIR DERIVATIVES.
DESAULLES PA; KRAEHENBUEHL C
Acta Endocrinol (Copenh); 1964 Nov; 47():444-56. PubMed ID: 14225842
[No Abstract] [Full Text] [Related]
35. [Luteolytic agents and reproduction].
Cortés-Gallegos V
Gac Med Mex; 1973 Oct; 106(4):259-86. PubMed ID: 4593968
[No Abstract] [Full Text] [Related]
36. [Effect of combined contraceptive tablets on blood levels of the gonadotropic hormones estradiol and progesterone (author's transl)].
Balogh A; Ditroi F; Batar I; Lampe L
Orvoskepzes; 1981; 56(3):220-8. PubMed ID: 12338270
[TBL] [Abstract][Full Text] [Related]
37. OPTIMUM DOSAGE FOR ESTROGEN-PROGESTOGEN BALANCE TO INHIBIT OVULATION.
JACKSON MC; LINN R
Int J Fertil; 1964; 9():75-86. PubMed ID: 14106271
[No Abstract] [Full Text] [Related]
38. [INDUCTION OF OVULATION BY GONADOTROPINS, INHIBITION OF OVULATION BY GESTAGENS].
HOHLWEG W; REIFFENSTUHL G; SCHMOER J
Bibl Gynaecol; 1965; 32():14-21. PubMed ID: 14238627
[No Abstract] [Full Text] [Related]
39. WHAT ARE THE DANGERS OF ORAL CONTRACEPTION?
SWYER GI
Proc R Soc Med; 1964 Mar; 57(3):210-2. PubMed ID: 14130875
[No Abstract] [Full Text] [Related]
40. [RESULTS IN THE USE OF ORAL OVULATION INHIBITORS (ORAL CONTRACEPTIVES)].
SWAAB LI
Ned Tijdschr Geneeskd; 1964 May; 108():1070-6. PubMed ID: 14156330
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
